Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH

PLoS ONE(2024)10.1371/journal.pone.0301711Source: DataRank Database

Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.12)OA: goldTopics (65)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Michael Bobardt ORCID,Daren Ure ORCID,Robert T. Foster ORCID,Philippe Gallay ORCID,Winston T Stauffer ORCID

Live enrichment

PubMed:38573968 PMC:PMC10994289 OpenAlex:https://openalex.org/W4393929844

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: 5R01AI143931-04

Non-immunosuppressive Sanglifehrin Analogs as Therapeutic Agents for Viral Hepatitis-induced Liver Damage Development

NIAID NIH HHS

Grant: R01 AI143931

FWCI

1.12

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0301711&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0301711&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0301711

journalhttps://doi.org/10.1371/journal.pone.0301711

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38573968

Fields of Study

Signaling Pathways in DiseaseToxin Mechanisms and ImmunotoxinsPharmacological Effects of Natural CompoundsAnimalsHumansMiceCarcinoma, HepatocellularCyclophilinsDiabetes MellitusDiet, High-FatDisease Models, AnimalLiverLiver NeoplasmsMice, Inbred C57BLNon-alcoholic Fatty Liver DiseasePeptidyl-Prolyl Isomerase FStreptozocin

MeSH Terms

Peptidyl-Prolyl Isomerase FAnimalsDiabetes MellitusDisease Models, AnimalCarcinoma, HepatocellularHumansLiverLiver NeoplasmsMice, Inbred C57BLStreptozocinCyclophilinsMiceDiet, High-FatNon-alcoholic Fatty Liver Disease

Keywords

SteatohepatitisCyclophilinFatty liverKnockout mouseBiologyCypaContext (archaeology)Diabetes mellitusCyclophilin AInternal medicineEndocrinologyPharmacologyMedicineDiseaseBiochemistryMolecular biologyGeneCarcinoma, HepatocellularScienceQLiver NeoplasmsRDiet, High-FatStreptozocinMice, Inbred C57BLMiceCyclophilinsDisease Models, AnimalLiverNon-alcoholic Fatty Liver DiseaseAnimalsHumansPeptidyl-Prolyl Isomerase FResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being